| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 64.6507 | 67 |
| GSM780708 | Untreated after 4 days (C2_1) | 80.4472 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 73.5019 | 70 |
| GSM780719 | Untreated after 4 days (C1_2) | 68.3692 | 68 |
| GSM780720 | Untreated after 4 days (C2_2) | 75.2987 | 71 |
| GSM780721 | Untreated after 4 days (C3_2) | 71.1622 | 69 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 70.4633 | 69 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 69.4997 | 69 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 68.6474 | 69 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 84.5742 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 75.035 | 70 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 73.9392 | 70 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.122 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 74.2546 | 70 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 66.4602 | 68 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 62.2624 | 66 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 65.1141 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 62.7337 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 106.41 | 76 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 76.736 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 76.4478 | 71 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 100.265 | 75 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 76.5853 | 71 |